Hot Products
| Catalog No. | Information |
| CFN99767 | Ethyl ferulate Ethyl ferulate has anti-inflammatory property, can reduce HIV replication, it shows inhibitive effect on platelet congregation induced by ADP. It also is a potent inducer of HO-1 for the protection of brain cells against oxidative and neurodegenerative conditions. |
| CFN97323 | Ethyl gallate Ethyl gallate has anti-cancer, antioxidant activities, it may be an alternative class of vasopressors for use in septic shock. Ethyl gallate can treat acute lung injury (ALI) mainly by reducing the total cells and infiltration of activated polymorphonuclear leukocytes (PMNs). Ethyl gallate inhibits Akt , NF-κB p-65, Bcl-2/Bax, and mRNA levels of MMP-2 and MMP-9. |
| CFN70034 | Ethyl salicylate Ethyl salicylate has anti-inflammatory and analgesic activities. |
| CFN00075 | Ethylamine Ethylamine and glutamic acid are substrates of theanine synthetase. |
| CFN99320 | Ethylparaben Ethylparaben is the ethyl ester of p-hydroxybenzoic acid, used as an antifungal preservative and food additive. It is a standardized chemical allergen, has a certain reproductive toxicity to F0 male Drosophila.The physiologic effect of ethylparaben is by means of Increased Histamine Release, and Cell-mediated Immunity. |
| CFN89061 | Etoposide Etoposide is a chemotherapy medication used for the treatments of a number of types of cancer. Etoposide inhibits DNA synthesis by forming a complex with topoisomerase II and DNA, it induces apoptosis in MCF-7 breast cancer cells. |
| CFN95771 | Etuycomanol |
| CFN92667 | Euchrenone A10 Reference standards. |
| CFN92669 | Euchrestaflavanone A Euchrestaflavanone A is an inhibitor of MRP1-like efflux activity in human erythrocytes. It reveals potent cytotoxicities against one or more cell lines with IC 50 values in the range of 4.5–9.961μM. |
| CFN96525 | Euchrestaflavanone B Euchrestaflavanone B shows antibacterial activity against Gram positive bacteria, Staphylococcus aureus, Bacillus subtilis and Bacillus cereus. Euchrestaflavanone B may function by inhibiting oncogenic disease, at least in part, through the inhibition of protein kinase CKII activity. |
